Olfactory stimulation for promoting development and preventing morbidity in preterm infants

Mikaela Lenells; Marcus Glenton Prescott; Katarzyna Wróblewska-Seniuk; Michelle Fiander; Roger Soll; Matteo Bruschettini

doi:10.1002/14651858.CD016074

Olfactory stimulation for promoting development and preventing morbidity in preterm infants

Cochrane Database Syst Rev. 2024 Aug 14;8(8):CD016074. doi: 10.1002/14651858.CD016074.

Authors

Mikaela Lenells^{1

2}, Marcus Glenton Prescott³, Katarzyna Wróblewska-Seniuk⁴, Michelle Fiander⁵, Roger Soll⁶, Matteo Bruschettini⁷

Affiliations

¹ Women and Children's Health, Karolinska Institute, Stockholm, Sweden.
² FoUU, Karolinska University Hospital, Stockholm, Sweden.
³ St. Olavs Hospital, Trondheim, Norway.
⁴ II Department of Neonatology, Poznan Univeristy of Medical Sciences, Poznan, Poland.
⁵ Cochrane Neonatal Group, Halifax, Canada.
⁶ Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
⁷ Cochrane Sweden, Department of Research and Education, Lund University, Skåne University Hospital, Lund, Sweden.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of olfactory stimulation with different odorants in the NICU for promoting development and preventing morbidity in preterm infants.

MeSH terms

Child Development
Humans
Infant, Newborn
Infant, Premature* / growth & development
Infant, Premature, Diseases / prevention & control
Odorants* / prevention & control
Randomized Controlled Trials as Topic
Smell / physiology